- Home
- IMUX vs PHUN Comparison
IMUX vs PHUN Comparison
Compare IMUX & PHUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- PHUN
- Stock Information
- Founded
- IMUX 2016
- PHUN 2009
- Country
- IMUX United States
- PHUN United States
- Employees
- IMUX N/A
- PHUN N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- PHUN EDP Services
- Sector
- IMUX Health Care
- PHUN Technology
- Exchange
- IMUX Nasdaq
- PHUN Nasdaq
- Market Cap
- IMUX 67.8M
- PHUN 64.1M
- IPO Year
- IMUX N/A
- PHUN N/A
- Fundamental
- Price
- IMUX $0.98
- PHUN $2.91
- Analyst Decision
- IMUX Strong Buy
- PHUN Buy
- Analyst Count
- IMUX 5
- PHUN 2
- Target Price
- IMUX $7.50
- PHUN $7.75
- AVG Volume (30 Days)
- IMUX 1.1M
- PHUN 379.0K
- Earning Date
- IMUX 08-07-2025
- PHUN 08-07-2025
- Dividend Yield
- IMUX N/A
- PHUN N/A
- EPS Growth
- IMUX N/A
- PHUN N/A
- EPS
- IMUX N/A
- PHUN N/A
- Revenue
- IMUX N/A
- PHUN $2,956,000.00
- Revenue This Year
- IMUX N/A
- PHUN $3.01
- Revenue Next Year
- IMUX N/A
- PHUN $50.72
- P/E Ratio
- IMUX N/A
- PHUN N/A
- Revenue Growth
- IMUX N/A
- PHUN N/A
- 52 Week Low
- IMUX $0.56
- PHUN $2.22
- 52 Week High
- IMUX $2.11
- PHUN $14.60
- Technical
- Relative Strength Index (RSI)
- IMUX 57.59
- PHUN 39.09
- Support Level
- IMUX $0.90
- PHUN $3.13
- Resistance Level
- IMUX $1.18
- PHUN $3.36
- Average True Range (ATR)
- IMUX 0.08
- PHUN 0.22
- MACD
- IMUX 0.02
- PHUN -0.04
- Stochastic Oscillator
- IMUX 49.70
- PHUN 10.23
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About PHUN Phunware Inc.
Phunware Inc is a software company. It is a cloud platform for mobile that provides companies with the products, solutions, and data and services necessary to engage, manage and monetize its mobile application audiences. It derives maximum revenue from United States. The company has two reportable segments: Software subscriptions and services; and Advertising. It derives maximum revenue from Software subscriptions and services.